ORGO
Organogenesis Holdings Inc
1.30$
+0.8%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 15.4% | 10.7% | -9.2% | 3.6% | 7.5% | 8.6% | -23.0% | -32.6% | 2.0% | 17.5% | 56.8% | -72.3% | 7.0% | |
| 3.5% | 12.3% | 5.6% | 3.2% | 3.8% | 5.1% | 7.2% | 4.5% | 4.6% | 3.1% | 33.2% | 3.7% | 6.1% | |
| 2.2% | 2.4% | 2.2% | 2.0% | 2.4% | 2.3% | 3.9% | 2.5% | 2.0% | 1.9% | 9.8% | 7.0% | 3.1% | |
| 2.8% | -2.7% | -18.8% | -5.8% | -12.0% | -5.4% | -23.9% | -37.8% | -19.9% | -19.4% | 189.4% | 18.5% | 1.1% | |
| 5.5% | 3.3% | 2.0% | 1.4% | 2.2% | 2.7% | 4.2% | 3.6% | 1.5% | 2.1% | 8.5% | 2.5% | 2.4% | |
| -5.5% | -3.3% | -2.0% | -1.4% | -2.2% | -2.7% | -4.2% | -3.6% | -1.5% | -2.1% | -8.5% | -2.5% | -2.4% | |
| – | – | – | – | – | 1.4% | 2.1% | 2.8% | 3.7% | 0.1% | 8.1% | – | – | |
| 0.0% | 0.3% | – | – | – | -20.1% | – | – | – | – | – | – | – | |
| – | – | – | – | -1.5% | -49.4% | -0.3% | -0.3% | -0.2% | -0.1% | -26.4% | -0.8% | -2.4% | |
| -1.3% | -1.8% | -2.4% | -1.3% | -1.5% | 26.6% | -2.4% | -0.3% | -6.8% | -2.1% | -54.3% | -28.6% | -10.5% | |
| 8.6% | 5.5% | -13.6% | 0.9% | 3.9% | 32.5% | -29.5% | -36.5% | -6.2% | 13.3% | -6.0% | -103.4% | -5.9% | |
| 9.9% | 7.3% | -11.3% | 2.2% | 5.3% | 6.0% | -27.2% | -36.2% | 0.6% | 15.4% | 48.3% | -74.9% | 4.6% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.